This Week’s Biotech Highlights
There weren’t exactly an Ark’s worth of devleopments this week, but what did develop came two-by-two.
This week saw two very public regulatory developments in the U.S.:
- The FDA took two heavy steps against highly visible advertising: they said that General Mills’ claims on Cheerios boxes that the cereal can help lower cholesterol means that Cheerios are a drug and should be tested and regulated accordingly; and they chastised a number of pharma companies for ads placed with Google because the ads (limited to 95 characters) do not contain the required risk information.
- Also in the U.S., Rep. Pallone
